Press Releases Canntab Therapeutics Limited

Equities

Market Closed - Canadian Securities Exchange Other stock markets 02:07:30 2023-10-04 pm EDT			5-day change	1st Jan Change
0.005 ^CAD	-.--%		-.--%	-.--%

Apr. 15	Canntab Therapeutics Limited announced that it expects to receive CAD 0.1 million in funding	CI
2023	Canntab Therapeutics Limited Provide an Update on Product Delivery	CI

Canadian Investment Regulatory Organization Trading Halt - PILL	23-10-05	AQ
Canntab Therapeutics Limited Provides Update on Application for Management Cease Trade Order	23-09-18	NE
CANNTAB ANNOUNCES APPOINTMENT OF RICHARD GOLDSTEIN AS INTERIM CEO	23-08-22	AQ
IIROC Trade Resumption - PILL	22-11-22	AQ
IIROC Trading Halt - PILL	22-11-21	AQ
CANNTAB ANNOUNCES APPOINTMENT OF RICHARD GOLDSTEIN AS INTERIM CEO	22-08-23	AQ
CANNTAB ANNOUNCES ITS ENTRANCE INTO THE NOVA SCOTIA CANNABIS MARKET	22-08-22	AQ
CANNTAB ANNOUNCES CHANGE OF AUDITOR	22-05-30	AQ
Canntab Therapeutics : 2022Feb28 Q3 Interim MD&A	22-04-29	PU
Canntab Therapeutics : 2022Feb28 q3 Interim FS	22-04-29	PU
Canntab Engages Hamish Sutherland as Strategic Advisor	22-04-13	AQ
CANNTAB ANNOUNCES CLOSING OF CONVERTIBLE DEBENTURE PRIVATE PLACEMENT, WARRANT EXPIRY EXTENSION AND CORPORATE UPDATE	22-02-01	AQ
Canntab Therapeutics : 2021Nov30 Q2 MD&A	22-02-01	PU
Canntab Therapeutics : 2021Nov30 Q2 Interim FS	22-02-01	PU
Levitee Labs Partners with Canntab Therapeutics to Provide Alternatives to Opioids	22-01-10	AQ
Canntab Announces Agreement with Pathway Health	21-12-02	AQ
IIROC Trade Resumption - PILL	21-11-11	AQ
IIROC Trading Halt - PILL	21-11-10	AQ
Canntab Therapeutics : Announces the Early Exercise of $1,259,250 Warrants	21-06-03	AQ
Canntab Therapeutics : Mourns the Loss of Co-Founder	21-05-25	AQ

No results for this search